5/9
04:12 pm
inab
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
5/9
04:00 pm
inab
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Low
Report
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
4/30
06:17 am
inab
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma [Yahoo! Finance]
Low
Report
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma [Yahoo! Finance]
4/30
06:05 am
inab
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
Medium
Report
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
4/24
08:07 am
inab
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting [Yahoo! Finance]
Medium
Report
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting [Yahoo! Finance]
4/24
08:00 am
inab
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Medium
Report
IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
4/16
04:29 pm
inab
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]
Low
Report
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]
4/16
04:05 pm
inab
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Low
Report
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
5/9/2024
04:00 pm
INAB
in8bio, inc.
MISS
Report
-2.8%
in8bio, inc.
11/9/2023
04:00 pm
INAB
in8bio, inc.
BEAT
Report
3.0%
in8bio, inc.
8/10/2023
04:15 pm
INAB
in8bio, inc.
BEAT
Report
1.7%
in8bio, inc.
5/12/2023
08:00 am
INAB
in8bio, inc.
BEAT
Report
6.8%
in8bio, inc.
5/9
04:08 pm
inab
Form 10-Q IN8BIO, INC. For: Mar 31
Medium
Report
Form 10-Q IN8BIO, INC. For: Mar 31
5/9
04:05 pm
inab
Form 8-K IN8BIO, INC. For: May 09
Low
Report
Form 8-K IN8BIO, INC. For: May 09
5/7
04:06 pm
inab
Form 424B5 IN8BIO, INC.
Low
Report
Form 424B5 IN8BIO, INC.
4/26
04:10 pm
inab
Form ARS IN8BIO, INC. For: Dec 31
Medium
Report
Form ARS IN8BIO, INC. For: Dec 31
4/26
04:04 pm
inab
Form DEFA14A IN8BIO, INC.
Medium
Report
Form DEFA14A IN8BIO, INC.
4/26
04:01 pm
inab
Form DEF 14A IN8BIO, INC. For: Jun 12
Medium
Report
Form DEF 14A IN8BIO, INC. For: Jun 12
3/14
04:12 pm
inab
Form 10-K IN8BIO, INC. For: Dec 31
Low
Report
Form 10-K IN8BIO, INC. For: Dec 31
3/14
04:10 pm
inab
Form 8-K IN8BIO, INC. For: Mar 14
Low
Report
Form 8-K IN8BIO, INC. For: Mar 14
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register